Who Owns Veracyte Stock?
NASDAQ: VCYTHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 118.80%
- Institutions (% of float)
- 119.94%
- Held by insiders
- 0.95%
- Institutional holders
- 533
- Institutions 99.1%
- Insiders 0.9%
- Public and other 0.0%
Who owns Veracyte stock?
Institutional investors own about 118.8% of Veracyte's shares, spread across 533 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.95% of VCYT.
The largest institutional holders are Blackrock Inc. (17.21%), FMR, LLC (8.07%) and State Street Corporation (6.86%). Together, the top 10 institutions control 58.8% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their VCYT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VCYT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 13.89M | 17.21% | +3.0% |
| FMR, LLC | 6.51M | 8.07% | -15.4% |
| State Street Corporation | 5.53M | 6.86% | +17.8% |
| Vanguard Portfolio Management LLC | 4.84M | 5.99% | +2.6% |
| Vanguard Capital Management LLC | 3.60M | 4.46% | +0.2% |
| ARK Investment Management, LLC | 2.96M | 3.67% | +29.1% |
| William Blair Investment Management, LLC | 2.71M | 3.36% | +89.2% |
| Dimensional Fund Advisors LP | 2.69M | 3.33% | -4.8% |
| GW&K Investment Management, LLC | 2.41M | 2.99% | +70.1% |
| Artisan Partners Limited Partnership | 2.31M | 2.87% | -58.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VCYT
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 4.79M | 5.93% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.53M | 3.14% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.33M | 2.89% |
| iShares Trust-iShares Russell 2000 ETF | 2.09M | 2.59% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.83M | 2.27% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.61M | 1.99% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 1.59M | 1.97% |
| ARK ETF Trust-ARK Innovation ETF | 1.50M | 1.86% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.05M | 1.31% |
| Professionally Managed Portfolios-Congress Small Cap Growth Fund | 1.00M | 1.24% |
Frequently asked questions
Who is the largest shareholder of Veracyte?
Blackrock Inc. is the largest institutional shareholder of VCYT, owning 17.21% of shares outstanding (13.89M shares) as of its latest 13F filing.
What percentage of Veracyte is owned by institutions?
Institutions own about 118.8% of VCYT shares and 119.9% of the public float.
How much of Veracyte do insiders own?
Insiders, such as officers and directors, own about 0.95% of VCYT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.